intoplicine has been researched along with Nausea in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayssas, M; Bruno, R; Kim, J; Klink-Alaki, M; Newman, BM; Newman, RA; Pazdur, R | 1 |
1 trial(s) available for intoplicine and Nausea
| Article | Year |
|---|---|
Phase I trial of intoplicine (RP 60475) administered as a 72 h infusion every 3 weeks in patients with solid tumors.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Area Under Curve; Female; Humans; Indoles; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasms; Pyridines; Treatment Outcome | 1999 |